Synthesis of (2-Aminopyrimidin-4-yl)(pyridin-4-yl)methanone and Derivatives
Synthesis · 16.11.2023 · 55 (22) · 3825-3832
DOI: 10.1055/a-2107-4571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 16.11.2023. Verfasst von Francis Giraud und 4 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Pyrido[3,4-g]quinazoline was previously identified as a relevant scaffold for protein kinase inhibition. In order to assess if the planarity of this heterocyclic system was essential to the protein kinase inhibitory potency observed in this series, new compounds were synthesized and evaluated, in which the central cycle was opened to provide (pyridin-4-yl)(pyrimidin-4-yl)methane derivatives, which were prepared from the corresponding ketone precursor. After preparing (2-aminopyrimidin-4-yl)(pyridin-4-yl)methanone, derivatives were synthesized and evaluated toward a panel of protein kinases. The results demonstrated that the planar pyrido[3,4-g]quinazoline tricyclic system was mandatory to maintain the protein kinase inhibitory potency in this series.
Zitieren
APA
Giraud, F., Anizon, F., Moreau, P., Josselin, B., & Ruchaud, S. (2023). Synthesis of (2-Aminopyrimidin-4-yl)(pyridin-4-yl)methanone and Derivatives. Synthesis, 55(22), 3825-3832. https://doi.org/10.1055/a-2107-4571
Vancouver
Giraud F, Anizon F, Moreau P, Josselin B, Ruchaud S. Synthesis of (2-Aminopyrimidin-4-yl)(pyridin-4-yl)methanone and Derivatives. Synthesis. 2023;55(22):3825-3832. doi:10.1055/a-2107-4571
BibTeX
@article{Giraud2023,
author = {Giraud, Francis and Anizon, Fabrice and Moreau, Pascale and Josselin, Béatrice and Ruchaud, Sandrine},
title = {Synthesis of (2-Aminopyrimidin-4-yl)(pyridin-4-yl)methanone and Derivatives},
journal = {Synthesis},
year = {2023},
volume = {55},
number = {22},
pages = {3825--3832},
doi = {10.1055/a-2107-4571}
}
EUVIMED